Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | KAT2B | Q92831 | 8/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 4/20 | 0.48 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29351451 | 0.86 | MAPT (0.63) | MAPTKDM4EKAT2BALDH1A1POLB | |
| SCHEMBL303646 | 0.86 | MAPT (0.63) | MAPTKDM4EKAT2BALDH1A1POLB | |
| SCHEMBL10622798 | 0.83 | KAT2B (0.72) | MAPTKDM4EKAT2BALDH1A1POLB | |
| SCHEMBL2228520 | 0.82 | KAT2B (0.66) | MAPTKDM4EKAT2BALDH1A1POLB | |
| SCHEMBL17923845 | 0.81 | KAT2B (0.64) | MAPTKDM4EKAT2BALDH1A1POLB | |
| SCHEMBL4557828 | 0.81 | KAT2B (0.64) | MAPTKDM4EKAT2BALDH1A1POLB | |
| SCHEMBL2228171 | 0.81 | KAT2B (0.64) | MAPTKDM4EKAT2BALDH1A1POLB | |
| SCHEMBL30413993 | 0.81 | KAT2B (0.64) | MAPTKDM4EKAT2BALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL4699216 | 0.80 | KAT2B (0.65) | MAPTKDM4EKAT2BALDH1A1POLB | |
| Ethylamine SCHEMBL5152975 | 0.79 | MAPT (0.50) | MAPTKDM4EKAT2BALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11419809-B2 | Hair treatment compositions and methods for treating hair | L'OREAL (FR) | 2022-08-23 | — | — | US | disclosed |
| US-11324689-B2 | Cosmetic compositions containing an alkoxysilane and a silsesquioxane resin | L'OREAL (FR) | 2022-05-10 | — | — | US | disclosed |
| US-20200405618-A1 | HAIR TREATMENT COMPOSITIONS AND METHODS FOR TREATING HAIR | L'OREAL (FR) | 2020-12-31 | — | — | US | disclosed |
| US-20200246247-A1 | COSMETIC COMPOSITIONS CONTAINING AN ALKOXYSILANE AND A SILSESQUIOXANE RESIN | L'OREAL (FR) | 2020-08-06 | — | — | US | disclosed |
| US-10596100-B2 | Cosmetic compositions containing an alkoxysilane and a silsesquioxane resin | L'OREAL (FR) | 2020-03-24 | — | — | US | disclosed |
| US-10576307-B2 | Hair-treatment compositions, methods, and kits for treating hair | L'OREAL (FR) | 2020-03-03 | — | — | US | disclosed |
| US-10561599-B2 | Methods and kits for treating chemically relaxed hair | L'OREAL (FR) | 2020-02-18 | — | — | US | disclosed |
| WO-2018218007-A1 | METHODS AND KITS FOR TREATING CHEMICALLY RELAXED HAIR | L'OREAL (FR) | 2018-11-29 | — | — | WO | disclosed |
| US-20180339175-A1 | HAIR-TREATMENT COMPOSITIONS, METHODS, AND KITS FOR TREATING HAIR | L'OREAL (FR) | 2018-11-29 | — | — | US | disclosed |
| US-20180338901-A1 | METHODS AND KITS FOR TREATING CHEMICALLY RELAXED HAIR | L'OREAL (FR) | 2018-11-29 | — | — | US | disclosed |
| WO-2012061267-A2 | TWO-STEP NAIL POLISH PRODUCT | L'OREAL SA (FR) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012061265-A2 | NITROCELLULOSE-FREE NAIL POLISH COMPOSITIONS | L'OREAL S.A. (FR) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012055812-A1 | COSMETIC COMPOSITION COMPRISING A FATTY-CHAIN ALKOXYSILANE AND AN ANTIDANDRUFF AGENT. | L'OREAL (FR) | 2012-05-03 | — | — | WO | disclosed |
| WO-2012055805-A1 | COSMETIC COMPOSITION COMPRISING A FATTY-CHAIN ALKOXYSILANE AND A SILICEOUS COSMETIC AGENT. | L'OREAL (FR) | 2012-05-03 | — | — | WO | disclosed |
| WO-2012055807-A1 | COSMETIC COMPOSITION COMPRISING A FATTY-CHAIN ALKOXYSILANE AND A CATIONIC POLYMER | L'OREAL (FR) | 2012-05-03 | — | — | WO | disclosed |
| WO-2012055806-A1 | COSMETIC COMPOSITION COMPRISING ONE OR MORE FATTY-CHAIN ALKOXYSILANES AND ONE OR MORE NON-SILICEOUS FATTY SUBSTANCES | L'OREAL (FR) | 2012-05-03 | — | — | WO | disclosed |
| WO-2012055811-A1 | COSMETIC COMPOSITION COMPRISING A FATTY-CHAIN ALKOXYSILANE AND A CATIONIC OR NONIONIC SURFACTANT. | L'OREAL (FR) | 2012-05-03 | — | — | WO | disclosed |
| WO-2012055809-A1 | COSMETIC COMPOSITION COMPRISING A FATTY-CHAIN ALKOXYSILANE, AN ANIONIC SURFACTANT AND A NONIONIC, AMPHOTERIC OR ZWITTERIONIC SURFACTANT | L'OREAL (FR) | 2012-05-03 | — | — | WO | disclosed |
| US-7740664-B2 | Composition comprising at least one silicone compound and at least one organosilane | L'OREAL S.A. (FR) | 2010-06-22 | — | — | US | disclosed |
| US-20090183320-A1 | Composition comprising at least one silicone compound and at least one organosilane | L'OREAL S.A. (FR) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10576307-B2 | Hair-treatment compositions, methods, and kits for treating hair | OTC, TET3, SUCLG1 | MAPT 2494/4885KDM4E 1056/4885KAT2B 1063/4885 |
| US-10561599-B2 | Methods and kits for treating chemically relaxed hair | CRAT, DNMT1, TET3 | MAPT 2881/4885KDM4E 489/4885KAT2B 853/4885 |
| US-20180339175-A1 | HAIR-TREATMENT COMPOSITIONS, METHODS, AND KITS FOR TREATING HAIR | OTC, TET3, SUCLG1 | MAPT 2494/4885KDM4E 1056/4885KAT2B 1063/4885 |
| US-10596100-B2 | Cosmetic compositions containing an alkoxysilane and a silsesquioxane resin | SRM, STS, SMS | MAPT 4429/4885KDM4E 926/4885KAT2B 1340/4885 |
| US-11419809-B2 | Hair treatment compositions and methods for treating hair | TET3, TET1, ALG3 | MAPT 2496/4885KDM4E 232/4885KAT2B 804/4885 |
| US-11324689-B2 | Cosmetic compositions containing an alkoxysilane and a silsesquioxane resin | SRM, STS, SMS | MAPT 4429/4885KDM4E 926/4885KAT2B 1340/4885 |
| US-20180338901-A1 | METHODS AND KITS FOR TREATING CHEMICALLY RELAXED HAIR | CRAT, DNMT1, TET3 | MAPT 2881/4885KDM4E 489/4885KAT2B 853/4885 |
| US-20090183320-A1 | Composition comprising at least one silicone compound and at least one organosilane | KRT18, VIM, SMC4 | MAPT 1180/4885KDM4E 370/4885KAT2B 148/4885 |
| US-20200405618-A1 | HAIR TREATMENT COMPOSITIONS AND METHODS FOR TREATING HAIR | TET3, TET1, ALG3 | MAPT 2496/4885KDM4E 232/4885KAT2B 804/4885 |
| US-20200246247-A1 | COSMETIC COMPOSITIONS CONTAINING AN ALKOXYSILANE AND A SILSESQUIOXANE RESIN | SRM, STS, SMS | MAPT 4429/4885KDM4E 926/4885KAT2B 1340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.